{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:50Z","timestamp":1792686470685,"version":"4.5.0"},"reference-count":151,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is one of the most interesting diseases in the field of maxillofacial surgery. In addition to bisphosphonates, the use of antiresorptive and antiangiogenic agents is known to be the leading cause. However, the exact pathogenesis of MRONJ has not been established, and various hypotheses have been proposed, such as oxidative stress-related theory. As a result, a definitive treatment protocol for MRONJ has not been identified, while various therapeutic approaches are applied to manage patients with MRONJ. Although the surgical approach to treat osteomyelitis of the jaw has been proven to be most effective, there are limitations, such as recurrence and delayed healing. Many studies and clinical trials are being conducted to develop another effective therapeutic modality. The use of some materials, including platelet concentrates and bone morphogenetic proteins, showed a positive effect on MRONJ. Among them, teriparatide is currently the most promising material, and it has shown encouraging results when applied to patients with MRONJ. Furthermore, cell therapy using mesenchymal stem cells showed promising results, and it can be the new therapeutic approach for the treatment of MRONJ. This review presents various treatment methods for MRONJ and their limitations while investigating newly developed and researched molecular and cellular therapeutic approaches along with a literature review.<\/jats:p>","DOI":"10.3390\/antiox10050680","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T06:19:11Z","timestamp":1619504351000},"page":"680","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6192-1530","authenticated-orcid":false,"given":"Sung-Woon","family":"On","sequence":"first","affiliation":[{"name":"Division of Oral and Maxillofacial Surgery, Department of Dentistry, Hallym University Dongtan Sacred Heart Hospital, Hwaseong 18450, Korea"},{"name":"Graduated School of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Institute of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3955-5623","authenticated-orcid":false,"given":"Seoung-Won","family":"Cho","sequence":"additional","affiliation":[{"name":"Graduated School of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Institute of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Division of Oral and Maxillofacial Surgery, Hallym University Sacred Heart Hospital, Anyang 14066, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0739-7971","authenticated-orcid":false,"given":"Soo-Hwan","family":"Byun","sequence":"additional","affiliation":[{"name":"Graduated School of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Institute of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Division of Oral and Maxillofacial Surgery, Hallym University Sacred Heart Hospital, Anyang 14066, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-6772","authenticated-orcid":false,"given":"Byoung-Eun","family":"Yang","sequence":"additional","affiliation":[{"name":"Graduated School of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Institute of Clinical Dentistry, Hallym University, Chuncheon 24252, Korea"},{"name":"Division of Oral and Maxillofacial Surgery, Hallym University Sacred Heart Hospital, Anyang 14066, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.19.02192","article-title":"Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial","volume":"38","author":"Sim","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J. Oral Maxillofac. Surg., 65, 369\u2013376.","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"ref_5","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 Update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: Different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: Elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: Current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: From the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: A possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2010","journal-title":"Clin. Oral Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.joms.2009.03.001","article-title":"Comprehensive review of bisphosphonate therapy: Implications for the oral and maxillofacial surgery patient","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates\u2014Histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.joms.2009.03.005","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: Bone scintigraphy as an early indicator","volume":"67","author":"Khoury","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_18","first-page":"350","article-title":"Introduction to osteonecrosis of the femoral head (OFH) and osteonecrosis of the jaw (ONJ)","volume":"7","author":"Kim","year":"2007","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","article-title":"Potential pathophysiological mechanisms in osteonecrosis of the jaw","volume":"1218","author":"Landesberg","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","article-title":"Antiresorptives and osteonecrosis of the jaw","volume":"12","author":"Yamashita","year":"2012","journal-title":"J. Evid.-Based Dent. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pimolbutr, K., Porter, S., and Fedele, S. (2018). Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naive Patient: A Comprehensive Review of the Literature. BioMed Res. Int., 2018.","DOI":"10.1155\/2018\/8071579"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2005.07.145","article-title":"Vascular endothelial growth factor receptors in osteoclast differentiation and function","volume":"335","author":"Aldridge","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djq516","article-title":"Osteonecrosis of the jaw and the role of macrophages","volume":"103","author":"Pazianas","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_25","first-page":"2893","article-title":"Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients","volume":"9","author":"Santini","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lombard, T., Neirinckx, V., Rogister, B., Gilon, Y., and Wislet, S. (2016). Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches. Stem Cells Int., 2016.","DOI":"10.1155\/2016\/8768162"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/jbmr.1669","article-title":"Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis","volume":"27","author":"Aguirre","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0765.1981.tb00976.x","article-title":"The progress of the periodontal syndrome in the rice rat. I. Morphometric and autoradiographic studies","volume":"16","author":"Gotcher","year":"1981","journal-title":"J. Periodontal Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","article-title":"Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice","volume":"28","author":"Kang","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.joms.2011.02.059","article-title":"Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: A study of the changes in the jaws","volume":"69","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.joms.2008.09.031","article-title":"Sinus tracts\u2014An early sign of bisphosphonate-associated osteonecrosis of the jaws?","volume":"67","author":"Mawardi","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.14219\/jada.archive.2009.0049","article-title":"Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1601-0825.2010.01739.x","article-title":"In vivo effects of zoledronic acid on oral mucosal epithelial cells","volume":"17","author":"Allam","year":"2011","journal-title":"Oral Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2011.181","article-title":"Epidemiology and pathogenesis of osteonecrosis of the jaw","volume":"8","author":"Reid","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/pr400050u","article-title":"Paraoxonase-1 deficiency is associated with severe liver steatosis in mice fed a high-fat high-cholesterol diet: A metabolomic approach","volume":"12","author":"Kensicki","year":"2013","journal-title":"J. Proteome Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopha.2011.06.003","article-title":"Oxidative stress and antioxidant status in prostate cancer patients: Relation to Gleason score, treatment and bone metastasis","volume":"65","author":"Battisti","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12011-013-9659-y","article-title":"Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat","volume":"153","author":"Kocer","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3855\/jidc.1906","article-title":"Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients","volume":"6","author":"Awodele","year":"2012","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lebreton, F., van Schaik, W., Sanguinetti, M., Posteraro, B., Torelli, R., Le Bras, F., Verneuil, N., Zhang, X., Giard, J.C., and Dhalluin, A. (2012). AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002834"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/152308602753625915","article-title":"Transcription factors regulating the response to oxidative stress in yeast","volume":"4","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/rheumatology\/keh518","article-title":"DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis","volume":"44","author":"Ichiseki","year":"2005","journal-title":"Rheumatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00776-004-0816-1","article-title":"Oxidative stress and vascular permeability in steroid-induced osteonecrosis model","volume":"9","author":"Ichiseki","year":"2004","journal-title":"J. Orthop. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/17453671003628772","article-title":"Vitamin E prevents steroid-induced osteonecrosis in rabbits","volume":"81","author":"Kuribayashi","year":"2010","journal-title":"Acta Orthop."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jop.12151","article-title":"Oxidative stress in bisphosphonate-related osteonecrosis of the jaws","volume":"43","author":"Bagan","year":"2014","journal-title":"J. Oral Pathol. Med."},{"key":"ref_46","first-page":"1440","article-title":"Osteonecrosis of the jaws caused by bisphosphonate treatment and oxidative stress in mice","volume":"17","author":"Tamaoka","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/JPER.19-0385","article-title":"Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: A pathogenesis of bisphosphonate-related osteonecrosis of the jaw","volume":"91","author":"Taniguchi","year":"2020","journal-title":"J. Periodontol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yatsuoka, W., Ueno, T., Miyano, K., Uezono, Y., Enomoto, A., Kaneko, M., Ota, S., Soga, T., Sugimoto, M., and Ushijima, T. (2019). Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220712"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Suzuki, K., Takeyama, S., Murakami, S., Nagaoka, M., Chiba, M., Igarashi, K., and Shinoda, H. (2020). Structure-Dependent Effects of Bisphosphonates on Inflammatory Responses in Cultured Neonatal Mouse Calvaria. Antioxidants, 9.","DOI":"10.3390\/antiox9060503"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jcms.2018.12.014","article-title":"Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study","volume":"47","author":"Ristow","year":"2019","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_51","first-page":"e141","article-title":"Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates","volume":"9","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.oooo.2016.11.011","article-title":"Bacterial diversity in medication-related osteonecrosis of the jaw","volume":"123","author":"Hallmer","year":"2017","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","article-title":"Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: A systematic review and meta-analysis of the drug suspension protocol","volume":"22","author":"Ramaglia","year":"2018","journal-title":"Clin. Oral Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of Adverse Events With Antibiotic Use in Hospitalized Patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Werner, N.L., Hecker, M.T., Sethi, A.K., and Donskey, C.J. (2011). Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-187"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jcms.2018.05.003","article-title":"Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up","volume":"46","author":"Nisi","year":"2018","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcms.2020.02.017","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) stage III: Conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic review","volume":"48","author":"Vanpoecke","year":"2020","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_59","first-page":"e788","article-title":"The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw","volume":"22","author":"Eguchi","year":"2017","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.adaj.2017.04.002","article-title":"Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis","volume":"148","author":"Sgro","year":"2017","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.joms.2015.01.008","article-title":"Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution","volume":"73","author":"Lopes","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Marciano, A., Rubino, E., Peditto, M., Mauceri, R., and Oteri, G. (2020). Oral Surgical Management of Bone and Soft Tissues in MRONJ Treatment: A Decisional Tree. Life, 10.","DOI":"10.3390\/life10070099"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.joms.2020.05.037","article-title":"Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study","volume":"78","author":"Giudice","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00784-013-0979-2","article-title":"Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study","volume":"18","author":"Lesclous","year":"2014","journal-title":"Clin. Oral Investig."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/odi.12764","article-title":"Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?","volume":"24","author":"Favia","year":"2018","journal-title":"Oral Dis."},{"key":"ref_67","first-page":"22","article-title":"Histology of the Oral Mucosa in Patients With BRONJ at III Stage: A Microscopic Study Proves the Unsuitability of Local Mucosal Flaps","volume":"5","author":"Lorenzo","year":"2013","journal-title":"J. Clin. Med. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jcms.2015.12.017","article-title":"The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"44","author":"Mucke","year":"2016","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.joms.2014.09.023","article-title":"Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw","volume":"73","author":"Rotaru","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10006-016-0597-7","article-title":"Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites","volume":"21","author":"Blus","year":"2017","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.joms.2017.10.024","article-title":"Can Autofluorescence Guide Surgeons in the Treatment of Medication-Related Osteonecrosis of the Jaw? A Prospective Feasibility Study","volume":"76","author":"Giudice","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Pellegrino, G., Pavanelli, F., Ferri, A., Lizio, G., Parrulli, R., and Marchetti, C. (2020). Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review. Methods Protoc., 3.","DOI":"10.3390\/mps3040070"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jcms.2016.06.016","article-title":"Bisphosphonate-related osteonecrosis of the jaws: Cohort study of surgical treatment results in seventy-four stage II\/III patients","volume":"44","author":"Pichardo","year":"2016","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08977190412331279890","article-title":"Bone morphogenetic proteins","volume":"22","author":"Chen","year":"2004","journal-title":"Growth Factors"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/SCS.0b013e31824dbdd4","article-title":"Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw","volume":"23","author":"Cicciu","year":"2012","journal-title":"J. Craniofacial Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2013.06.192","article-title":"Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein","volume":"72","author":"Gerard","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","article-title":"Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?","volume":"75","author":"Park","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jcpe.12270","article-title":"Effect of rhBMP-2 dose on bone formation\/maturation in a rat critical-size calvarial defect model","volume":"41","author":"Pelaez","year":"2014","journal-title":"J. Clin. Periodontol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1902\/jop.2002.73.9.1020","article-title":"Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration","volume":"73","author":"Selvig","year":"2002","journal-title":"J. Periodontol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0022034513518561","article-title":"Bone morphogenetic proteins: Facts, challenges, and future perspectives","volume":"93","author":"Carreira","year":"2014","journal-title":"J. Dent. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.joms.2003.12.003","article-title":"Platelet-rich plasma: Evidence to support its use","volume":"62","author":"Marx","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Rasmusson","year":"2009","journal-title":"Trends Biotechnol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review","volume":"44","author":"Tobias","year":"2016","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: A prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5999\/aps.2013.40.5.530","article-title":"Platelet-rich plasma: Quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups","volume":"40","author":"Lee","year":"2013","journal-title":"Arch. Plast. Surg."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.tripleo.2005.07.009","article-title":"Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archsurg.1990.01410130103015","article-title":"Oxygen as an antibiotic. The effect of inspired oxygen on bacterial clearance","volume":"125","author":"Knighton","year":"1990","journal-title":"Arch. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0278-2391(83)80005-6","article-title":"A new concept in the treatment of osteoradionecrosis","volume":"41","author":"Marx","year":"1983","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_91","first-page":"5","article-title":"Ozone and its usage in general medicine and dentistry. A review article","volume":"109","author":"Seidler","year":"2008","journal-title":"Prague Med. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0278-2391(83)90294-X","article-title":"Osteoradionecrosis: A new concept of its pathophysiology","volume":"41","author":"Marx","year":"1983","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archsurg.1984.01390140057010","article-title":"Oxygen as an antibiotic. The effect of inspired oxygen on infection","volume":"119","author":"Knighton","year":"1984","journal-title":"Arch. Surg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.71.405","article-title":"Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs","volume":"71","author":"Asano","year":"2007","journal-title":"Circ. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.ASW.0000280198.81130.d5","article-title":"Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: A preliminary study","volume":"20","author":"Boykin","year":"2007","journal-title":"Adv. Skin Wound Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cardiores.2006.06.031","article-title":"Hyperoxic and hyperbaric-induced cardioprotection: Role of nitric oxide synthase 3","volume":"72","author":"Cabigas","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1152\/jn.2000.83.4.2022","article-title":"Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain","volume":"83","author":"Elayan","year":"2000","journal-title":"J. Neurophysiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2310\/6670.2006.00057","article-title":"Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing","volume":"14","author":"Gallagher","year":"2006","journal-title":"Vascular"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neuroscience.2005.07.061","article-title":"Oxygen-induced mitochondrial biogenesis in the rat hippocampus","volume":"137","author":"Gutsaeva","year":"2006","journal-title":"Neuroscience"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00268-003-7400-2","article-title":"Oxygen in wound healing--more than a nutrient","volume":"28","author":"Tandara","year":"2004","journal-title":"World J. Surg."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"H1378","DOI":"10.1152\/ajpheart.00888.2005","article-title":"Stem cell mobilization by hyperbaric oxygen. American journal of physiology","volume":"290","author":"Thom","year":"2006","journal-title":"Heart Circ. Physiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"17497","DOI":"10.1074\/jbc.M409332200","article-title":"Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast","volume":"280","author":"Bai","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","article-title":"A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation","volume":"106","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevEukaryotGeneExpr.v14.i4.20","article-title":"Regulatory mechanisms operative in osteoclasts","volume":"14","author":"Reddy","year":"2004","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.joms.2007.03.019","article-title":"Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: A case series","volume":"65","author":"Freiberger","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: A randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Sacco, R., Leeson, R., Nissan, J., Olate, S., Bettoni Cruz de Castro, C.H., Acocella, A., and Lalli, A. (2019). A systematic review of oxygen therapy for the management of medication-related osteonecrosis of the jaw (MRONJ). Appl. Sci., 9.","DOI":"10.3390\/app9051026"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1590\/1413-785220182601179926","article-title":"Could Ozone Treatment Be a Promising Alternative for Osteomyelitis? An Experimental Study","volume":"26","author":"Bilge","year":"2018","journal-title":"Acta Ortop. Bras."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.arcmed.2005.08.006","article-title":"Scientific and medical aspects of ozone therapy. State of the art","volume":"37","author":"Bocci","year":"2006","journal-title":"Arch. Med. Res."},{"key":"ref_110","first-page":"353","article-title":"The use of ozone in dentistry and maxillofacial surgery: A review","volume":"37","author":"Stubinger","year":"2006","journal-title":"Quintessence Int."},{"key":"ref_111","first-page":"4","article-title":"Experimental-morphological study of the anti-inflammatory action of ozone-perfluorane complex application","volume":"87","author":"Guchetl","year":"2008","journal-title":"Stomatologiia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/01.scs.0000249350.59096.d0","article-title":"New therapeutic protocol in the treatment of avascular necrosis of the jaws","volume":"17","author":"Agrillo","year":"2006","journal-title":"J. Craniofacial Surg."},{"key":"ref_113","first-page":"1741","article-title":"Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy","volume":"16","author":"Agrillo","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: A correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1563\/1548-1336(2007)33[371:UOPPIT]2.0.CO;2","article-title":"Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: A report of 2 cases","volume":"33","author":"Lee","year":"2007","journal-title":"J. Oral Implantol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/scs.0b013e31857261f","article-title":"Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis","volume":"18","author":"Agrillo","year":"2007","journal-title":"J. Craniofacial Surg."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/pho.2011.3219","article-title":"Laser GaAlAs (lambda860 nm) photobiomodulation for the treatment of bisphosphonate-induced osteonecrosis of the jaw","volume":"30","author":"Paraguassu","year":"2012","journal-title":"Photomed. Laser Surg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10103-010-0816-7","article-title":"Low-level laser therapy supported teeth extractions of two patients receiving IV zolendronate","volume":"26","author":"Kan","year":"2011","journal-title":"Lasers Med. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/pho.2009.2501","article-title":"Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: Preliminary results of a prospective study","volume":"28","author":"Scoletta","year":"2010","journal-title":"Photomed. Laser Surg."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10103-009-0687-y","article-title":"Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)","volume":"25","author":"Vescovi","year":"2010","journal-title":"Lasers Med. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/pho.2010.2955","article-title":"Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): A retrospective analysis of 101 treated sites with long-term follow-up","volume":"30","author":"Vescovi","year":"2012","journal-title":"Photomed. Laser Surg."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10103-016-1929-4","article-title":"Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): A systematic review","volume":"31","author":"Weber","year":"2016","journal-title":"Lasers Med. Sci."},{"key":"ref_124","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen. Dent."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Son, H.J., Kim, J.W., and Kim, S.J. (2019). Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw. Maxillofac. Plast. Reconstr. Surg., 41.","DOI":"10.1186\/s40902-019-0210-8"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","article-title":"Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: A pooled case report analysis","volume":"73","author":"Hinson","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5125\/jkaoms.2014.40.5.206","article-title":"Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw","volume":"40","author":"Kim","year":"2014","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jcms.2017.07.014","article-title":"Relevant factors for treatment outcome and time to healing in medication-related osteonecrosis of the jaws\u2014A retrospective cohort study","volume":"45","author":"Martins","year":"2017","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00774-019-01035-7","article-title":"Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw","volume":"38","author":"Hayashida","year":"2020","journal-title":"J. Bone Miner. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/odi.12966","article-title":"Drug holiday patterns and bisphosphonate-related osteonecrosis of the jaw","volume":"25","author":"Jung","year":"2019","journal-title":"Oral Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5125\/jkaoms.2020.46.1.78","article-title":"The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction","volume":"46","author":"Kang","year":"2020","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ottesen, C., Schiodt, M., and Gotfredsen, K. (2020). Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review. Heliyon, 6.","DOI":"10.1016\/j.heliyon.2020.e03795"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: A decade of experience","volume":"27","author":"Cipriani","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","article-title":"Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies","volume":"116","author":"Langdahl","year":"2018","journal-title":"Bone"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Napoli, N., Strollo, R., Paladini, A., Briganti, S.I., Pozzilli, P., and Epstein, S. (2014). The alliance of mesenchymal stem cells, bone, and diabetes. Int. J. Endocrinol., 2014.","DOI":"10.1155\/2014\/690783"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00223-018-0485-2","article-title":"Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies","volume":"104","author":"Silverman","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","article-title":"Teriparatide and osseous regeneration in the oral cavity","volume":"363","author":"Bashutski","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.080807","article-title":"Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)]","volume":"23","author":"Vahle","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exphem.2007.11.007","article-title":"Mesenchymal cells recruit and regulate T regulatory cells","volume":"36","author":"Moretti","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Cella, L., Oppici, A., Arbasi, M., Moretto, M., Piepoli, M., Vallisa, D., Zangrandi, A., Di Nunzio, C., and Cavanna, L. (2011). Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med., 7.","DOI":"10.1186\/1746-160X-7-16"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/scd.2012.0615","article-title":"Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in swine","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/ten.tea.2009.0577","article-title":"Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo","volume":"17","author":"Zimmermann","year":"2011","journal-title":"Tissue Eng. Part A"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1242\/dev.023788","article-title":"Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration","volume":"135","author":"Leucht","year":"2008","journal-title":"Development"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/SCS.0b013e3182869968","article-title":"Cell therapy in bisphosphonate-related osteonecrosis of the jaw","volume":"24","author":"Villanueva","year":"2013","journal-title":"J. Craniofacial Surg."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10266-017-0295-4","article-title":"Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells","volume":"105","author":"Voss","year":"2017","journal-title":"Odontology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/0284186X.2020.1730004","article-title":"Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: Report of two cases","volume":"59","author":"Orellana","year":"2020","journal-title":"Acta Oncol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/10\/5\/680\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:53:12Z","timestamp":1760161992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/10\/5\/680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":151,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["antiox10050680"],"URL":"https:\/\/doi.org\/10.3390\/antiox10050680","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}